person · Reporting owner
Eldracher Deborah DiSanzo
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BEST BUY CO INCBBY · Entity 3305 | President, Best Buy Health | October 17, 2022 | October 18, 2022 |
| Lifeward Ltd.RWLK · Entity 7620 | Director | April 30, 2018 | May 02, 2018 |
| NOVANTA INCNOVT · Entity 3857 | Director | January 03, 2022 | January 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BEST BUY CO INC
Report date October 17, 2022 · Filed October 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,412 |
Reported balance
After 2022-10-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-10-17 · Sale · Disposed 28 · Balance 21,412 F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.
F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).
Lifeward Ltd.
Report date April 30, 2018 · Filed May 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.01 per shareSEC Table I · non-derivative | IndirectESOP | 22,727 |
Reported balance
After 2018-04-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-04-30 · Grant · Acquired 22,727 · Balance 22,727 F1: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant.
NOVANTA INC
Report date January 03, 2022 · Filed January 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,705 |
Reported balance
After 2022-01-04 transaction · row 1
1 source rowRow 1 · 2022-01-04 · Exercise / conversion · Acquired 531 · Balance 1,705 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-01-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-01-04 · Exercise / conversion · Disposed 531 · Balance 0 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 359 |
Reported balance
After 2022-01-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-01-03 · Grant · Acquired 359 · Balance 359 F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,064 |
Reported balance
After 2022-01-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-01-03 · Grant · Acquired 359 · Balance 2,064 F4: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.
F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).
F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.
F4: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 17, 2022 Filed Oct 18, 2022 20:28 UTC | BEST BUY CO INC BBY · Entity 3305 | SaleCommon Stock | 28 | $64.58 | $1,808.18 |
DisclosureSEC source: 0001225208-22-011020 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,412 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:33 UTC | BEST BUY CO INC BBY · Entity 3305 | SaleCommon Stock | 1,834 | $71.58 | $131,274.05 |
DisclosureSEC source: 0001225208-22-010447 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,169 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 22:15 UTC | BEST BUY CO INC BBY · Entity 3305 | SaleCommon Stock | 799 | $99.06 | $79,150.54 |
DisclosureSEC source: 0001225208-22-005015 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,606 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. Read SEC document |
| March 20, 2022 Filed Mar 22, 2022 21:52 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 7,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004964 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,405 F1 · shares: Restricted shares that will vest in three equal annual installments beginning one year from the grant date. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:38 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 5,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004545 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,795 F1 · shares: Represents restricted shares earned pursuant to an award approved by the Issuer on March 20, 2021, which was subject to achievement of positive adjusted net earnings as of the end of any fiscal year during the term of the award (the 'Performance Condition'). Satisfaction of the Performance Condition was approved by the Compensation and Human Resources Committee of the Board of Directors on March 9, 2022. The restricted shares will vest in three equal annual installments beginning March 20, 2022. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 21:35 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionRestricted Stock Units · Derivative | 531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-000874 · form4.xml · derivative · entry 2 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 21:35 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionCommon Stock | 531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-000874 · form4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:35 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-000874 · form4.xml · derivative · entry 4 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,064 Underlying: Common Stock · 359 shares Expires not disclosed F4 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:35 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 359 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000874 · form4.xml · derivative · entry 3 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359 Underlying: Common Stock · 359 shares Expires not disclosed F2 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F2 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 20:34 UTC | BEST BUY CO INC BBY · Entity 3305 | SaleCommon Stock | 14 | $107.65 | $1,507.04 |
DisclosureSEC source: 0001225208-21-013087 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,344 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:58 UTC | BEST BUY CO INC BBY · Entity 3305 | SaleCommon Stock | 1,776 | $107.18 | $190,346.35 |
DisclosureSEC source: 0001225208-21-012508 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,278 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person. F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c). Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:43 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-001018 · form4.xml · derivative · entry 4 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,705 Underlying: Common Stock · 531 shares Expires not disclosed F4 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F4 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:43 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001018 · form4.xml · derivative · entry 3 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531 Underlying: Common Stock · 531 shares Expires not disclosed F2 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F2 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:43 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionRestricted Stock Units · Derivative | 682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-001018 · form4.xml · derivative · entry 2 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:43 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionCommon Stock | 682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-001018 · form4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| September 20, 2020 Filed Sep 22, 2020 20:54 UTC | BEST BUY CO INC BBY · Entity 3305 | GrantCommon Stock | 11,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011741 · doc4.xml · nonDerivative · entry 1 Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,840 F1 · shares: Restricted shares that will vest in three equal annual installments beginning one year from the grant date. Read SEC document |
| May 11, 2020 Filed May 12, 2020 20:44 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionRestricted Stock Units · Derivative | 492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-016294 · form4.xml · derivative · entry 2 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| May 11, 2020 Filed May 12, 2020 20:44 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionCommon Stock | 492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-016294 · form4.xml · nonDerivative · entry 1 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:39 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-001236 · form4.xml · derivative · entry 2 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,174 Underlying: Common Stock · 682 shares Expires not disclosed F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:39 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001236 · form4.xml · derivative · entry 1 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682 Underlying: Common Stock · 682 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:41 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018332 · form4.xml · derivative · entry 2 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492 Underlying: Common Stock · 492 shares Expires not disclosed F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:41 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-018332 · form4.xml · derivative · entry 1 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492 Underlying: Common Stock · 492 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| April 30, 2018 Filed May 2, 2018 20:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000020 · wf-form4_152529133599383.xml · nonDerivative · entry 1 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 22,727 F1 · shares: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 12:16 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 4,176 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-17-006791 · wf-form4_149873860066032.xml · derivative · entry 1 Disanzo Deborah · CIK 0001661251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,176 Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares Expires 2027-06-27 F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.